Ronald L. Davis

Risks, advantages, and complications of intercostal vs subcostal approach for percutaneous nephrolithotripsy.

M. Allaf, L. Myers, Raju Thomas, 2009, Urology.

Granulocytes as an effector mechanism of BCG therapy for bladder cancer.

Wenjun Le, Zheng Cui, Ronald L. Davis, 2017, Medical hypotheses.

MP13-19 A PHASE II/III TRIAL OF CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-REFRACTORY NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)

D. Lamm, K. Chamie, G. Steinberg, 2016 .

Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.

J. W. Stallings, C. Ryan, D. Huo, 2007, Urology.

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.

D. Lamm, K. Chamie, J. Gutheil, 2017, Urologic oncology.